A recent clinical trial has demonstrated that the drug, IONIS-HTTRx, is safe for use in people with Huntington’s disease.
A preliminary clinical study has demonstrated that the experimental drug tofersen may be effective in the treatment of a genetic form of ALS.
A Phase III study has shown that cannabidiol can reduce seizures by almost half in children with Dravet syndrome, a rare type of severe epilepsy.
Neonatologists have determined that there may be links between disruption of placental allopregnanolone delivery to the fetus and brain injuries associated with autism.
Researchers have developed a device that utilizes brain activity to control a virtual vocal tract; this could enhance the communication of individuals who have lost the ability to speak.
People who were previously housebound with Parkinson’s disease are now able to walk more freely thanks to spinal stimulation treatment.
Yale scientists have partially restored brain circulation and function in post-mortem pig brains for up to 4 hours after death; this may raise ethical and legal questions about the nature of death and consciousness.
Home technology including artificial intelligence, robotics and sleep monitoring may become standard in the homes of people living with dementia, researchers indicate.
The Epilepsy Society is calling for the UK government to regulate flashing images online. This will help to safeguard individuals with photosensitive epilepsy.